Today, CELLINK launches the C.WASH, an innovative liquid handling system for media change in cellular assays and tipless magnetic bead washing. Among other workflows, the C.WASH will help with high-throughput COVID-19 testing and research. The C.WASH offers a non-contact method of performing complex washing tasks, enabling automated and highly reproducible washing of micro well plates using centrifugal forces. It improves workflows by reducing costs and saving time when performing high throughput screening, cell-based assays and magnetic bead based nucleic acid extractions.To bring the C.WASH to market, CELLINK has signed a license agreement with AusBio Laboratories Co Ltd. to use their technology in the system. The benchtop device will be exclusively distributed worldwide by the CELLINK group and will be sold under the CYTENA brand as part of the Liquid Handling & Bioprocessing business area. The C.WASH will further broaden CELLINK’s instrument portfolio for applications in drug discovery, single-cell analysis and next-generation sequencing.
“We are thrilled to be launching the C.WASH and partnering with AusBio. This is a great step forward for the Liquid Handling & Bioprocessing business area as we continue to break down barriers and provide our customers in the life science community with highly efficient workflows in high-throughput screening and library prep for sequencing.”
—Jonas Schöndube, Business Area Manager at CELLINK, CEO at CYTENA GmbH
For further information, please contact:
Erik Gatenholm, CEO
Phone (Sweden): +46 73 267 00 00
Phone (US): +1 (650) 515 5566
Gusten Danielsson, CFO
Phone (Sweden): +46 70 991 86 04
Phone (US): +1 (857) 332 2138
This information was submitted for publication, through the agency of the contact persons set out above, on October 21, 2020 at 11:30 CET.